MicroRNA responses to cellular stress.

Recent work has begun to explore the instrumental role that small noncoding RNA species, particularly microRNAs (miRNA), have both in classifying human tumors and in directing embryonic development. These studies suggest that developmental programs in essentially all organisms studied are set, in part, by varied expressions of miRNAs and that neoplasia is characterized by altered expression of miRNAs. Reasoning that these observations are linked, we examined whether cellular exposures that induce both developmental anomalies and cancer alter miRNAs. Using microarrays of 385 known human miRNAs, we studied human lymphoblastoid cells grown under various conditions or treatments. Folate deficiency induced a pronounced global increase in miRNA expression. We observed no significant alteration in miRNA expression in cells treated with gamma-irradiation, whereas exposure to sodium arsenite led to global increases in miRNA expression. The miRNA hsa-miR-222 was identified from these arrays as significantly overexpressed under folate-deficient conditions, and this finding was confirmed in vivo in human peripheral blood from individuals with low folate intake. Alterations to cellular miRNA expression profiles represent a novel mode of action of folate deprivation and arsenic exposure, and specific alterations in miRNA expression may be a powerful biomarker for these and other toxins with serious effects on human health.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  Martin Vingron,et al.  Variance stabilization applied to microarray data calibration and to the quantification of differential expression , 2002, ISMB.

[3]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[4]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[5]  R. Berry,et al.  Periconceptional use of multivitamins and the occurrence of neural tube defects. , 1989, JAMA.

[6]  E. Rimm,et al.  Folate, methionine, and alcohol intake and risk of colorectal adenoma. , 1993, Journal of the National Cancer Institute.

[7]  Jie Liu,et al.  Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. , 2004, Carcinogenesis.

[8]  R. Löwer,et al.  DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas , 1999, British Journal of Cancer.

[9]  P. Jones,et al.  Hypomethylation of DNA in the regulation of gene expression. , 1988, Developmental biology.

[10]  R. Plasterk,et al.  MicroRNA function in animal development , 2005, FEBS letters.

[11]  Yoshikazu Nakamura,et al.  Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells. , 2004, Biochemical and biophysical research communications.

[12]  C. Croce,et al.  The role of microRNA genes in papillary thyroid carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[14]  R. Aharonov,et al.  Identification of hundreds of conserved and nonconserved human microRNAs , 2005, Nature Genetics.

[15]  B. Diwan,et al.  Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Heimburger,et al.  DNA methylation and diet in cancer. , 2002, The Journal of nutrition.

[17]  Apiwat Mutirangura,et al.  Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis , 2004, Oncogene.

[18]  C. Croce,et al.  MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Stempak,et al.  Cell and stage of transformation-specific effects of folate deficiency on methionine cycle intermediates and DNA methylation in an in vitro model. , 2005, Carcinogenesis.

[20]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[21]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[22]  W. Morgan,et al.  Gene expression profiling after irradiation: Clues to understanding acute and persistent responses? , 2004, Cancer and Metastasis Reviews.

[23]  T. Rossman.  Mechanism of arsenic carcinogenesis: an integrated approach. , 2003, Mutation research.

[24]  D. Bartel,et al.  MicroRNA-Directed Cleavage of HOXB8 mRNA , 2004, Science.

[25]  D. Bartel,et al.  Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs , 2004, Nature Reviews Genetics.

[26]  D. Meek,et al.  Mechanisms of switching on p53: a role for covalent modification? , 1999, Oncogene.

[27]  A. Smith,et al.  Cancer risks from arsenic in drinking water. , 1992, Environmental health perspectives.

[28]  W. Willett,et al.  Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. , 2003, Journal of the National Cancer Institute.

[29]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Rimm,et al.  Joint association of alcohol and folate intake with risk of major chronic disease in women. , 2003, American journal of epidemiology.

[31]  Muller Fabbri,et al.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.

[32]  C. Croce,et al.  MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[34]  I. Pogribny,et al.  Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. , 2003, The Journal of nutrition.

[35]  W J Schull,et al.  Radiation-related brain damage and growth retardation among the prenatally exposed atomic bomb survivors. , 1998, International journal of radiation biology.

[36]  W. Willett,et al.  Reproducibility and validity of a semiquantitative food frequency questionnaire. , 1985, American journal of epidemiology.

[37]  Ellen A Eisen,et al.  The ADH1C Polymorphism Modifies the Risk of Squamous Cell Carcinoma of the Head and Neck Associated with Alcohol and Tobacco Use , 2005, Cancer Epidemiology Biomarkers & Prevention.

[38]  E. Miska,et al.  MicroRNA functions in animal development and human disease , 2005, Development.

[39]  Michael L Bittner,et al.  Stress-specific signatures: expression profiling of p53 wild-type and -null human cells , 2005, Oncogene.

[40]  Schull Wj,et al.  Review: Radiation-related brain damage and growth retardation among the prenatally exposed atomic bomb survivors , 1998 .